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 he aim of this study was to evaluate histologically, three types of calcium sulfate - Merck (Brazil), Surgiplaster (Italy) and
Capset (USA) - in surgically created defects on rabbit femurs. Twenty male New Zealand rabbits were used. Two surgical bone
defects (5 mm diameter x 8 mm depth) were created on each distal epiphysis using a #3 Dentoflex trephine bur. Defects were
filled with: group 1 - di-hydrated calcium sulfate (Merck); group 2 - Capset (Lifecore-USA); group 3 - Surgiplaster (Classimport-
Italy); group 4 – control (blood clot). The animals were sacrificed 30, 60, 90 and 180 days postoperatively. Semi-serial 6-mm-
thick sections were obtained, stained with hematoxylin and eosin and examined under light microscopy. Bone defects treated
with calcium sulfate exhibited new bone formation regardless of the product trademark.
Uniterms: Calcium sulfate; Bone defect; Bone regeneration.
INTRODUCTION
Several surgical procedures using biological or synthetic
bone substitutes have been developed for the treatment of
bone defects to promote closure with new bone tissue with
morphological and functional characteristics similar to those
of the original tissue1,2,11,12,17. The ideal graft material should
be biocompatible, non antigenic, non carcinogenic,
osteoinduction, osteoconductive, low cost and gradual
substitute of bone tissue5,11,14,21,22.
The autogenous bone ís the most widely used graft
material due its favorable biological properties in terms of
the formation of new bone tissue. Nevertheless, the most of
the time is unviable due insufficient amounts of autogenous
bone, size of defects, disconfort for the patient, the need for
extensive and long-lasting surgery to obtain the graft and
the risk of infecction at the donor site13,14,16.
Calcium sulfate used as bone implant material has been
reviewed by several authors 1,2,3,8,10,12,17,20. Calcium sulfate or
plaster of Paris has a long clinical history as a bone graft
material substitute in various skeletal sites including
mandibular1, craniofacial12  and long bone defects10-15 and
benign bone lesions12. Calcium sulfate also has been used
as a barrier in guided tissue regeneration by physically
halting soft connective tissue proliferation by means of the
osteopromotion principle4,8,18,19,25
The aim of this study was to evaluate histologically the
tissue reaction to three types of calcium sulfate: di-hydrate
calcium sulfate (Merck, Brazil), Capset (Lifecore Medicals,
USA) and Surgiplaster (Classimport, Italy) when used in
surgical cavities on femurs epiphisis rabbits.
MATERIAL AND METHODS
Twenty male New Zealand rabbits aged between 9 and
12 months with body mass between 3.5 kg and 4.0 kg,
obtained from the Central Animal Laboratory of the Dental
School of Bauru, USP, were used. The experiment was made
in conformity with the Ethical Principles of Animal
Experimentation of the Brazilian College of Animal
Experimentation (COBEA).
All animals were submitted to surgery under general
anesthesia with intra-muscular injection of xylazine/ketamine
(AgriBrands LtdaTM, Paulinia, SP, Brazil). After trichotomy
of the internal femur region and disinfection with iodine
alcohol solution (Povidine), a linear incision was made in
the lining epithelium of the tibia-femur junction with # 15
surgical blade. The flap was elevated with a Molt spatula,
exposing the bone surface of the femoral epiphysis. With a
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#3 surgical trephine bur (Dentoflex), two cavities was created
(5 mm in diameter x 8 mm in depth) on each femoral epiphysis
(right and left) under copious saline irrigation.
The animals were divided into four groups: group 1 (5
animals) the defect was filled with dehydrated calcium sulfate
(Merck, Rio de Janeiro, RJ, Brazil); group 2 (5 animals) filled
with Capset (Lifecore Biomedicals, Inc., Chaska, MN, USA);
group 3 (5 animals) filled with Surgiplaster (Classimport,
Italy); group 4 (control group) filled with blood clot.
The materials were mixed with blood taken from the ear
lobule and applied in the cavities using a graft carrier. The
implants were randomized into the surgical sites. Flap was
placed in position and closed with # 4 Vicryl (Poliglactine
910, Johnson & Johnson, São José dos Campos, SP, Brazil).
The rabbits were sacrificed with an anesthetic overdose
30, 60, 90 and 180 days after surgery. The femoral epiphysis
were collected and fixed in 10% formalin for 1 week,
demineralized in Morse solution for 40 days, dehydrated in
ethanol, cleared with xylene and embedded in Histosec. The
blocks were cut into semi-serial 6-mm-thick sections and
stained with hematoxylin and eosin.
All histological sections were analyzed under light
microscopy (AxioscopTM ,Carl Zeiss, Germany) and the
following events were determined: presence of blood clot,
inflammatory cell infiltrate, intensity of angiogenesis, bone
formation and organization, resorption of graft material and
closure of bone defects.
RESULTS
30-day Period
In the control group (blood clot), primary bone tissue
formation occurred in hubcap form, which closed the cavity
opening. In the region toward to the medullar canal, a thin
bone layer was formed interlocked with connective tissue.
Between the defect borders, there was a small amount of
newly formed bone (Figure 1a). Callus bone tissue was
observed covered by a dense periosteum. None of the
defects presented connective tissue invagination.
The defects treated with Surgiplaster showed two tiny
bands of primary bone tissue. The external band had a
continuous aspect and the internal band had a fragmented
aspect, between them there was connective tissue that was
being replaced by myeloid tissue (Figure 1b). Between the
defect borders, a small bone area was observed; however it
did not close the defect and was thinner than the original
bone tissue. In the more internal portion of the defect, there
were some bone bands interlocked with a great amount of
myeloid tissue, or tiny bone formations surrounded by cells
and blood vessel-rich tissue.
In the defects treated with Capset bone trabeculae were
formed and were projected to the middle of the defect along
with the invaginated connective tissue.(Figure 1c). There
was a bone tissue filling with thin and scattered bands, in
addition to abundant connective tissue. There was neither
bone callus formation in this group nor presence of
periosteum or bone bands connected to the myeloid tissue.
Defects filled with Merck calcium sulfate showed
connective tissue formation occupying partially the middle
area of the defects. In this case, new bone formation occurred
from the invaginated border to the medullar canal
accompanying the margins of this connective tissue (Figure
1d).
60-day period
In the defects treated with blood clot, an intense bone
tissue formation occurred from the defect borders, with a
greater thickness. However, in all cases, the bone tissue in
the defect central area was not as thick as in other areas,
and sometimes was interrupted by a connective tissue
bundle (Figure 2a).
The defects treated with Surgiplaster showed, in some
cases, bone deposition extending from the defect border
and several bone bands invading the medullar canal and
demarcating spaces occupied by myeloid tissue. In the
central region, connective tissue bundles were noticed,
being replaced by bone tissue. In two cases, a tiny bone
formation occurred in the defect border and the central
region was occupied by myeloid tissue covered by
connective tissue (Figure 2b).
Defects treated with Capset (Figure 2c) and Merck
calcium sulfate (Figure 2d) were similar, that is, in three cases
there was tiny bone formation in the border and a large
central empty area occupied by connective tissue. In the
other cases, the defect was closed by remodeling bone
tissue, which was thinner than the original bone tissue.
90-day and 180-day periods
In both periods, the histological appearance was similar.
In the defects filled with blood clot (Figure 3a), complete
defect closure occurred by a compact arrangement of bone
tissue projections thinner than the original cortical bone,
with a small central depression. In the groups treated with
Surgiplaster (Figure 3b), Capset (Figure 3c) and Merck
calcium sulfate (Figure 3d), all the defects were filled with
two compact bone corticals thinner than the defect borders
with a central region occupied by myeloid tissue.
DISCUSSION
It has been shown that the hemihydrate calcium sulfate,
also called, plaster of Paris, is safe and effective for a variety
of clinical applications, such as medical and dental
orthopedics6,7,9,10,19. Moreover, calcium sulfate has also been
used as a biological barrier in guided tissue regeneration,
hindering physically the proliferation of connective and
epithelial tissue cells from the bone defect, allowing bone
regeneration by the principle of osteopromotion19,23. In the
present work, the bone defects showed new bone formation
in all studied groups, regardless of the commercial brand of
the product used.
Surgiplaster, after 30 days, promoted the formation of
thin bone trabeculae filled by a connective tissue being
replaced by myeloid tissue. Merck and Capset calcium sulfate
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showed total or partial formation of a conjunctive fibrosis
occupying the central area of the defect. In these cases, the
newly formed bone from the defect border invaginated to
the interior of the medullar canal following the edges of this
connective tissue. In these 30-day specimens, the presence
of the calcium sulfate was not detected in the defective
area. It is possible that a faster resorption of the material has
contributed for connective tissue formation in the defect in
cases filled with calcium sulfate from Merck and Capset.
Due to the fact that the initial period was 30 days, it was not
possible to know when this occurred and whether it could
have some difference between materials.
Victor, et al.24 (1975), showed that the calcium sulfate
was resorbed within 30 days and well tolerated by the
organism. Murashima, et al.17 (2002) using Surgiplaster in
bone defects prepared in jaws of Beagle dogs after
apicoectomy did not observe the presence of Surgiplaster,
8 and 16 weeks after surgical interventions.
Some bone defects filled by Surgiplaster presented, after
60 days, formation of a disorganized bone tissue extending
from the bone edge with innumerable bone projections that
invaded the medullar canal and whose inter-trabecular
spaces were occupied by myeloid tissue. The central region
of the defect presented a connective tissue bundle being
replaced by newly formed bone.
However, the bone defects filled with Merck and Capset
calcium sulfate (3 cases each) presented little bone formation
in the border and a great central portion filled with the
connective tissue. In the other cases, closing of the bone
defect due to formation of bone tissue thinner than the
original bone, with presence of connective tissue occupying
partially the central area of the defect. In these cases, the
new bone formation from the border of the defect
invaginated to the interior of the medullar canal following
the edges of the connective tissue.
At 90 and 180 days, the defects presented similar
histological appearance. In the groups treated with calcium
sulfate, all defects were filled at the site of the original cortical
by two parallel compact cortical bones, both thinner than
the border of the defect, delimiting with the central region
filled with myeloid tissue.
CONCLUSIONS
Surgical cavities filled with calcium sulfate revealed new
bone formation in all studied groups, regardless of the
commercial brand of the product used.
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